Data from GDC-0980 Is a Novel Class I PI3K/mTOR Kinase Inhibitor with Robust Activity in Cancer Models Driven by the PI3K Pathway

MLA

Lori S. Friedman, et al. Data from GDC-0980 Is a Novel Class I PI3K/MTOR Kinase Inhibitor with Robust Activity in Cancer Models Driven by the PI3K Pathway. Apr. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....344448ff3a06fe2f5d7081d2a898c2c2&authtype=sso&custid=ns315887.

APA

Lori S. Friedman, Marcia Belvin, Deepak Sampath, Mark R. Lackner, Leanne Ross, Robert Kassees, Letitia Lensun, Sonal Patel, Jill M. Spoerke, Carol O’Brien, Daniel P. Sutherlin, Alan G. Olivero, Laurent Salphati, Jodie Pang, Jim Nonomiya, Cristina Lewis, John D. Lesnick, Leslie Lee, Wei Wei Prior, … Jeffrey J. Wallin. (2023). Data from GDC-0980 Is a Novel Class I PI3K/mTOR Kinase Inhibitor with Robust Activity in Cancer Models Driven by the PI3K Pathway.

Chicago

Lori S. Friedman, Marcia Belvin, Deepak Sampath, Mark R. Lackner, Leanne Ross, Robert Kassees, Letitia Lensun, et al. 2023. “Data from GDC-0980 Is a Novel Class I PI3K/MTOR Kinase Inhibitor with Robust Activity in Cancer Models Driven by the PI3K Pathway,” April. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....344448ff3a06fe2f5d7081d2a898c2c2&authtype=sso&custid=ns315887.